Mainboard · BSE and NSEDraft filed
Rodec Pharma Limited IPO: dates, price band, lot size, objects of the issue
Get updates on this IPO
Dates, price band, allotment and listing notices by email, and new views from SEBI-registered research analysts on InsightPier by email.Dates, allotment, listing and analyst views. Stop anytime.
By continuing you agree to the Terms and Privacy policy
Key facts
- Price band
- Not announced
- Lot size
- Not announced
- Lot amount at the upper band
- Not announced
- Issue size at the upper band
- 56,50,000 shares (Amount not stated in the draft)
- DRHP dated Sun 11 Jan 2026, page 88
- Bid dates
- Not announced
- Listing date
- Not announced
- Proposed exchanges
- BSE and NSE
Timeline (IST)
- Draft filedTue 20 Jan 2026 confirmedDRHP dated Sun 11 Jan 2026
- OpensDates to be announced
- ClosesDates to be announced
- AllotmentDates to be announced
- Refund and unblockDates to be announced
- ListingDates to be announced
Company and promoters
As described in the DRHP
We are engaged in the business of manufacturing of animal feed supplements and marketing veterinary pharmaceutical drugs and animal feed supplements to address healthcare and nutritional requirements of livestock animals for the animal healthcare sector.
DRHP dated Sun 11 Jan 2026, page 30
Promoters
- 3 individual promoters
DRHP dated Sun 11 Jan 2026, page 30
Shareholding
| Holding | Before the issue | After the issue |
|---|---|---|
| Promoters and promoter group | 92.40% | Not stated in the DRHP |
| Public | 7.60% | Not stated in the DRHP |
DRHP dated Sun 11 Jan 2026, page 114
Financials (restated)
| Item | September 30, 2025 | March 31, 2025 | March 31, 2024 | March 31, 2023 |
|---|---|---|---|---|
| Revenue from operations | ₹62.73 crore | ₹106.39 crore | ₹88.42 crore | ₹71.61 crore |
| Profit after tax | ₹9.73 crore | ₹18.26 crore | ₹11.04 crore | ₹5.21 crore |
| Net worth | ₹59.96 crore | ₹50.04 crore | ₹31.75 crore | Not stated in the draft |
| Total borrowings | Not stated in the draft | Not stated in the draft | Not stated in the draft | Not stated in the draft |
DRHP dated Sun 11 Jan 2026, page 94
Who is selling in the offer for sale
| Selling shareholder | Type | Shares offered | Amount at the upper band |
|---|---|---|---|
| Individual shareholder | Individual | 56,50,000 | Not announced |
| Total offer for sale | Not stated in the draft | ||
DRHP dated Sun 11 Jan 2026, page 88
Peer comparison (as in the DRHP)
| Name of the Company | Face Value (₹ Per share) | Closing Price (₹ Per share) | Revenue from Operations for Fiscal 2025 (₹ in million) | EPS (₹ Per share) Basic | EPS (₹ Per share) Diluted | NAV (₹ Per share) | P/E Ratio | RoNW (%) Financial Year 2025 |
|---|---|---|---|---|---|---|---|---|
| Rodec Pharma Limited* | 10 | [●] | 1,063.93 | 8.08 | 8.08 | 22.15 | [●] | 36.49 |
| Hester Biosciences Limited | 10 | 1560.60 | 3,111.02 | 33.89 | 33.89 | 383.99 | 46.05 | 8.82 |
| Sequent Scientific Limited | 2 | 198.57 | 15,513.70 | 0.88 | 0.85 | 30.78 | 233.61 | 4.19 |
| Alembic Pharmaceuticals Limited | 2 | 799.95 | 66,720.80 | 29.68 | 29.68 | 264.03 | 26.95 | 11.22 |
Reproduced from the DRHP dated Sun 11 Jan 2026, pages 134 to 135; InsightPier adds no figures
Risk factors
71 total- Depends on a few third-party manufacturers to make its veterinary drug products (DRHP page 35)
- Most revenue comes from two segments: veterinary drugs and animal feed supplements (DRHP page 35)
- Revenue is concentrated in Uttar Pradesh (DRHP page 35)
- A significant share of revenue comes from certain key customers (DRHP page 35)
- Manufacturing is at a single facility in Ghaziabad (DRHP page 35)